I haven't seen anything to suggest that this is definitely off track. The peer review phase may take about 3 months*, which means that the results can be verified and peer-reviewed by March (which is still Q1 2018). The timeline only says that these results are likely to be published in the Q2 edition of a medical journal.
With the peer-reviewed clinicial trial data, the FDA shouldn't take more than 3 weeks* to process and hopefully approve a submission.
* I got these estimates from asking a friend who is doing his Masters after graduating in Medical Science. So I'm not claiming to know these timeframes for sure, but he probably knows a thing or two about the scientific process in medical research
anticipated results, page-36
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.55M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16000 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 189950 | 2 |
View Market Depth
| Last trade - 08.22am 25/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable
